Study Exclusion reasons Remarks Reference(s)
Hazan, 2021 case series no control group

Hazan S et al. medrxiv;2021.07.06.21259924v1 10.1101/2021.07.06.21259924

Nasir, 2020 non randomized controlled trial no clinically relevant endpoint

Nasir A et al. 10.2139/ssrn.3734478

Cadegiani -Iver, 2020 observational study other unappropriated control group

Cadegiani FA medrxiv

IFORS (Pott-Junior), 2020 randomized controlled trial other The article has been retracted by Toxicology Reports

Pott-Junior H Toxicol Rep 2021;8:505-510. 10.1016/j.toxrep.2021.03.003

Elgazzar - treatment, 2020 randomized controlled trial other withdrawal of the publication

Elgazzar A et al. 10.21203/

Niaee (vs placebo), 2020 randomized controlled trial other On 8 October 2021 and 9 October 2021, two articles were published by subject-matter experts outlining concerns about various aspects of the study and, in particular, calling into question the randomization of participants. The authors and publishing journal have been alerted to these issues, and this note will be updated with any new information related to the publication.

Niaee MS et al. researchsquare 10.21203/

Niaee MS et al. Asian Pacific Journal of Tropical Medicine 10.4103/1995-7645.318304